Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-002238
Filing Date
2025-04-01
Accepted
2025-04-01 21:09:49
Documents
1
Period of Report
2025-03-30

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3367
  Complete submission text file 0001641172-25-002238.txt   4876
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Issuer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 23 WATERCRESS IRVINE CA 92603
Business Address
Fry Simon Jeremy (Reporting) CIK: 0002046305 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41245 | Film No.: 25801724